vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
21.34
+0.54 (2.61%)
May 12, 2025, 4:00 PM - Market closed
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $68.45 million as of May 12, 2025. Its market cap has decreased by -10.87% in one year.
Market Cap
68.45M
Enterprise Value
31.79M
1-Year Change
-10.87%
Ranking
Category
Stock Price
$21.34
Market Cap Chart
Since July 30, 2015, vTv Therapeutics's market cap has decreased from $357.30M to $68.45M, a decrease of -80.84%. That is a compound annual growth rate of -15.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 66.30M | 50.68% |
| Dec 31, 2024 | 44.00M | 46.18% |
| Dec 29, 2023 | 30.10M | -56.57% |
| Dec 30, 2022 | 69.30M | -22.66% |
| Dec 31, 2021 | 89.60M | -34.79% |
| Dec 31, 2020 | 137.40M | 34.97% |
| Dec 31, 2019 | 101.80M | -5.74% |
| Dec 31, 2018 | 108.00M | -45.23% |
| Dec 29, 2017 | 197.20M | 24.42% |
| Dec 30, 2016 | 158.50M | -29.08% |
| Dec 31, 2015 | 223.50M | -37.45% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |